93.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$103.96
Aprire:
$99.81
Volume 24 ore:
986.56K
Relative Volume:
1.72
Capitalizzazione di mercato:
$6.00B
Reddito:
$1.33B
Utile/perdita netta:
$120.04M
Rapporto P/E:
45.57
EPS:
2.05
Flusso di cassa netto:
$172.71M
1 W Prestazione:
-9.77%
1M Prestazione:
-7.95%
6M Prestazione:
-1.92%
1 anno Prestazione:
+30.37%
Merit Medical Systems Inc Stock (MMSI) Company Profile
Nome
Merit Medical Systems Inc
Settore
Industria
Telefono
(801) 253-1600
Indirizzo
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Confronta MMSI con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MMSI
Merit Medical Systems Inc
|
93.50 | 6.00B | 1.33B | 120.04M | 172.71M | 2.05 |
![]()
ISRG
Intuitive Surgical Inc
|
459.87 | 166.19B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
208.50 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
83.95 | 42.07B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
207.28 | 30.34B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
29.12 | 15.25B | 17.28B | 108.00M | 391.00M | 0.20 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-28 | Iniziato | JP Morgan | Overweight |
2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2024-06-28 | Iniziato | Robert W. Baird | Outperform |
2024-04-11 | Iniziato | CL King | Buy |
2024-02-07 | Iniziato | BofA Securities | Neutral |
2023-12-21 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2022-12-20 | Downgrade | Canaccord Genuity | Buy → Hold |
2021-01-05 | Aggiornamento | Needham | Hold → Buy |
2020-09-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2020-02-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2020-02-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2019-12-12 | Downgrade | Wells Fargo | Market Perform → Underperform |
2019-09-24 | Iniziato | Oppenheimer | Outperform |
2019-09-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
2019-07-26 | Downgrade | Needham | Buy → Hold |
2019-07-26 | Downgrade | Wells Fargo | Outperform → Market Perform |
2018-10-02 | Reiterato | Needham | Buy |
2018-08-07 | Downgrade | BofA/Merrill | Buy → Underperform |
2018-07-24 | Reiterato | Needham | Buy |
2018-06-01 | Reiterato | Needham | Buy |
2018-05-18 | Reiterato | SunTrust | Buy |
2018-04-26 | Reiterato | Needham | Buy |
2018-04-20 | Iniziato | Needham | Buy |
2018-03-01 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2017-08-28 | Downgrade | Raymond James | Strong Buy → Outperform |
2017-07-20 | Iniziato | BofA/Merrill | Buy |
2017-06-20 | Iniziato | SunTrust | Buy |
2017-04-05 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Merit Medical Systems Inc Borsa (MMSI) Ultime notizie
Merit Medical stock falls; BofA cites China tariff risks - Investing.com
Which GCs Sold Stock In March? Broadcom, Meta And More - Law360
Global Microcatheter Market Deep Research 2025-2032 | - openPR.com
Biopsy Devices Market Projected To Witness Massive Growth, - openPR.com
3 Reasons to Avoid MMSI and 1 Stock to Buy Instead - Yahoo Finance
Merit Medical Systems COO Neil Peterson sells shares for $522,650 By Investing.com - Investing.com South Africa
Merit Medical Systems COO Neil Peterson sells shares for $522,650 - Investing.com India
How Do Investors Really Feel About Merit Medical Systems? - Benzinga
Percutaneous Drainage Catheters Market Outlook 2024-2031: Top - openPR.com
(MMSI) Investment Report - news.stocktradersdaily.com
Brachytherapy Market Is Expected to Generate USD 1.6 Billion - openPR.com
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now - Nasdaq
Vanguard Group Inc. Buys 63,314 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) - MarketBeat
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)? - simplywall.st
JPMorgan starts Merit Medical with Overweight, $120 target - Investing.com Australia
JPMorgan starts Merit Medical with Overweight, $120 target By Investing.com - Investing.com Canada
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Assessing Merit Medical Systems: Insights From 12 Financial Analysts - Benzinga
JPMorgan Initiates Merit Medical Systems at Overweight With $120 Price Target - MarketScreener
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - The Manila Times
Major Breakthrough: Merit Medical's GERD Solution Achieves 94% Success in New Guidelines - Stock Titan
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results - Zacks Investment Research
Merit Medical releases 12-month efficacy results of WRAPSODY WAVE trial - TipRanks
Advancements In Peripheral Support Catheters Driving The Market: Key Trend Transforming the Transradial Acc... - WhaTech
Merit Medical Announces 12-Month Efficacy Results For WRAPSODY CIE In Hemodialysis Patients - Nasdaq
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - The Manila Times
Merit Medical Systems Reports Promising Six-Month and Twelve-Month Results for WRAPSODY CIE in WAVE Trial - Nasdaq
Merit Medical's WRAPSODY Achieves 70% Success Rate vs 41% Standard Treatment - Stock Titan
Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch - Yahoo Finance
(MMSI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Biopsy Devices Market Generated Opportunities, Future Scope - openPR
Prostatic Artery Embolization Market Is Booming Worldwide - openPR
Merit Medical Systems, Inc. Rings the Opening Bell - Nasdaq
Merit Medical Systems, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership - The Manila Times
U.S. Uterine Fibroid Treatment Market Future Business - openPR
Major Trend In The Procedure Trays Global Market 2025-2034: Innovative Solutions For Patient Safety Merit M... - WhaTech
Gastrointestinal Stent Market Booms with 6.0% CAGR Growth | TOP - openPR
Merit Medical: A Success Story That Keeps Getting Better - Seeking Alpha
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study - Yahoo Finance
Interventional Neuroradiology Market Expansion: From $1.9B - openPR
Charles Schwab Investment Management Inc. Boosts Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) - Defense World
Operating Procedure Trays Market: Key Drivers and Market - openPR
Merit Medical enrols first subject in trial of Bloom Micro Occluder System - Yahoo Finance
First patient enrolled in Merit Medical occluder system study - Mass Device
First Patient Enrolled in Merit Medical's PREEMIE Study - The Manila Times
Merit Medical Begins Clinical Trial for Groundbreaking Premature Baby Heart Treatment - StockTitan
Merit Medical Systems, Inc. to Host Earnings Call - ACCESS Newswire
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) CEO Sells $3,252,895.20 in Stock - Defense World
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Sells $3,087,000.00 in Stock - Defense World
Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Edgestream Partners L.P. - MarketBeat
Merit Medical Systems Inc Azioni (MMSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Merit Medical Systems Inc Azioni (MMSI) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Peterson Neil | CHIEF OPERATING OFFICER |
Apr 01 '25 |
Sale |
104.53 |
5,000 |
522,650 |
28,369 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):